Plasma kinetics of mitoxantrone in leukemic patients
- 1 September 1984
- journal article
- research article
- Published by Springer Nature in Medical Oncology and Tumor Pharmacotherapy
- Vol. 1 (3) , 201-204
- https://doi.org/10.1007/bf02934142
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Acute cardiovascular and renal changes induced by mitoxantrone in rabbits. A pharmacokinetic approachToxicology Letters, 1983
- Comparison of cardiotoxicity of two anthracenediones and doxorubicin in ratsToxicology Letters, 1982
- Pharmacology of mitoxantrone in cancer patientsCancer Chemotherapy and Pharmacology, 1982
- PHASE-I STUDY OF A 5-DAY SCHEDULE OF MITOXANTRONE (DIHYDROXYANTHRACENEDIONE)1982
- SAFETY ASSESSMENT OF A NEW ANTICANCER COMPOUND, MITOXANTRONE, IN BEAGLE DOGS - COMPARISON WITH DOXORUBICIN .2. HISTOLOGIC AND ULTRASTRUCTURAL PATHOLOGY1982
- SAFETY ASSESSMENT OF A NEW ANTICANCER COMPOUND, MITOXANTRONE, IN BEAGLE DOGS - COMPARISON WITH DOXORUBICIN .1. CLINICAL OBSERVATIONS1982
- Plasma levels of 1,4-dihydroxy-5,8-bis ({2-[(2--hydroxylethyl)amino]ethyl}amino)-9,10-anthracenedione dihydrochloride (DHAD) in humansInternational Journal of Pharmaceutics, 1981
- An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in SerumJournal of Liquid Chromatography, 1980
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetics and metabolism of adriamycin in manClinical Pharmacology & Therapeutics, 1973